Trials / Completed
CompletedNCT00745966
Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder
A 8-Week, Multicenter, Open-Label, Observational Study of Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to reassure the clinical study data on atypical antipsychotics effect on quality of life in Korean Bipolar patients.
Conditions
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2008-09-01
- First posted
- 2008-09-03
- Last updated
- 2008-10-06
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00745966. Inclusion in this directory is not an endorsement.